Diphenyl(N-methyl-2-pyrrolidinyl)methanol | 16226-56-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: Diphenyl(N-methyl-2-pyrrolidinyl)methanol
• 英文别名: (N-Methyl-pyrrolidynyl-2)-diphenyl-carbinol；Diphenyl-(N-methyl-α-pyrrolidyl)-carbinol；(1-methyl-pyrrolidin-2-yl)-diphenyl-methanol；(1-Methylpyrrolidin-2-yl)-diphenylmethanol
• CAS: 16226-56-5
• 化学式: C₁₈H₂₁NO
• 分子量: 267.371
• InChiKey: XIJAGFLYYNXCAB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  20
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  23.5
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  二苯甲酮 、 N-Methyl-2-(tributylstannyl)pyrrolidine 在 正丁基锂 、 四甲基乙二胺 作用下， 生成 Diphenyl(N-methyl-2-pyrrolidinyl)methanol
  参考文献：
  名称：

  Alkylation of 2-lithio-N-methylpiperidines and -pyrrolidines: scope, limitations, and stereochemistry

  摘要：

  The scope and limitations of the alkylation of racemic and nonracemic 2-lithiopiperidines and -pyrrolidines, obtained by transmetalation of the corresponding stannanes, is reported. These organolithiums react with a variety of electrophiles to afford 2-substituted pyrrolidines and piperidines in excellent yield. With primary alkyl halides the reaction proceeds with net inversion of configuration at the metal-bearing carbon in the piperidines; in the pyrrolidines there is a mixture of inversion and retention, with the former predominating. With most carbonyl electrophiles (carbon dioxide, dimethyl carbonate, methyl chloroformate, pivaloyl chloride, benzaldehyde, and dialkyl ketones), retention is observed in both cases. Electrophiles such as benzophenone, benzyl bromide, and tert-butyl bromoacetate afford racemic coupling products. A mechanistic interpretation is presented.

  DOI：

  10.1021/jo00123a008
• 作为试剂：
  描述：

  对甲氧基苯硼酸酐 、 苯甲醛 在 diethylzinc 、 Diphenyl(N-methyl-2-pyrrolidinyl)methanol 作用下， 以 正己烷 、 甲苯 为溶剂， 反应 20.0h， 生成 (S)-(4-methoxyphenyl)phenylmethanol 、 (R)-(4-methoxyphenyl)phenylmethanol
  参考文献：
  名称：

  以环硼氧烷为芳基源的催化不对称芳基转移至醛的反应

  摘要：

  在衍生自（S）-脯氨酸的手性氨基醇的存在下，以高对映选择性进行了三苯基硼氧杂环丁烷向一组芳基醛的不对称芳基转移。在苯甲醛的不对称芳基化反应中，取代的苯基硼氧还用作芳基来源。

  DOI：

  10.1016/j.tetasy.2005.06.010

文献信息

• PYRROLIDINE COMPOUND
  申请人：SUMITOMO CHEMICAL COMPANY, LIMITED

  公开号：US20180127364A1

  公开（公告）日：2018-05-10

  Compound (1) is useful as a catalyst since compound (III) can be obtained by reacting compound (I) with compound (II) in the presence of compound (I). In particular, an optically active substance of compound (III) can be produced by using compound (I) which is optically active.

  化合物（1）作为催化剂很有用，因为在化合物（1）的存在下，可以通过将化合物（I）与化合物（II）反应来获得化合物（III）。特别是，可以通过使用具有光学活性的化合物（I）来生产具有光学活性的化合物（III）的物质。
• PROCESS FOR THE PREPARATION OF DEUTERATED COMPOUNDS CONTAINING N-ALKYL GROUPS
  申请人：Atzrodt Jens

  公开号：US20140081019A1

  公开（公告）日：2014-03-20

  The present invention relates to a process for deuteration of amines in the alpha and/or beta position of the N-atom by using a deuterium source and a Ruthenium(II) based catalyst.

  本发明涉及一种利用氘源和基于二价钌的催化剂对胺在N原子的α和/或β位置进行氘代反应的方法。
• Novel imidazole derivatives, production method thereof and use thereof
  申请人：——

  公开号：US20040033935A1

  公开（公告）日：2004-02-19

  The present invention provides a compound having a steroid C 17,20 -lyase-inhibitory activity and useful for the therapy and prophylaxis of tumor such as prostatism, breast cancer and the like, and a method for efficiently separating an optically active compound of this compound from a mixture of optical isomers thereof, a compound of the formula: 1 wherein each symbol is as defined in the specification, a salt thereof or a prodrug thereof, and a method for obtaining an optically active compound by optically resolving a mixture of optical isomers by the use of a resolving agent such as tartranilic acid and the like.

  本发明提供一种具有类固醇C17,20-裂解酶抑制活性的化合物，用于治疗和预防前列腺癌、乳腺癌等肿瘤，以及一种有效地从其光学异构体混合物中分离出该化合物的光学活性化合物的方法，该化合物的化学式为：1其中每个符号如规范中定义，其盐或前药，以及通过使用像酞氨酸等分离剂对光学异构体混合物进行光学分离来获得光学活性化合物的方法。
• COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
  申请人：Zhang Jiazhong

  公开号：US20110263595A1

  公开（公告）日：2011-10-27

  Compounds and salts thereof, formulations thereof, conjugates thereof, derivatives thereof, forms thereof and uses thereof are described. In certain aspects and embodiments, the described compounds or salts thereof, formulations thereof, conjugates thereof, derivatives thereof, forms thereof are active on one or more of Fms, Kit, Flt3, TrkA, TrkB and TrkC kinase protein. Also described are methods of use thereof to treat diseases and conditions, including diseases and conditions associated with activity of one or more of Fms, Kit, Flt3, TrkA, TrkB and TrkC, including rheumatoid arthritis, osteoarthritis, osteoporosis, peri-prosthetic osteolysis, systemic sclerosis, demyelinating disorders, multiple sclerosis, Charcot Marie Tooth syndrome, amyotrophic lateral sclerosis, Alzheimer's disease, Parkinson's disease, global ischemia, ulcerative colitis, Crohn's disease, immune thrombocytopenic purpura, atherosclerosis, systemic lupus erythematosis, myelopreparation for autologous transplantation, transplant rejection, glomerulonephritis, interstitial nephritis, Lupus nephritis, tubular necrosis, diabetic nephropathy, renal hypertrophy, type I diabetes, acute pain, inflammatory pain, neuropathic pain, acute myeloid leukemia, melanoma, multiple myeloma, breast cancer, prostate cancer, pancreatic cancer, lung cancer, ovarian cancer, gliomas, glioblastoma, neurofibromatosis, osteolytic bone metastases, brain metasteses, gastrointestinal stromal tumors, and giant cell tumors.

  描述了化合物及其盐、配方、共轭物、衍生物、形式和用途。在某些方面和实施例中，所述化合物或其盐、配方、共轭物、衍生物、形式对Fms、Kit、Flt3、TrkA、TrkB和TrkC激酶蛋白中的一个或多个具有活性。还描述了使用方法，用于治疗与Fms、Kit、Flt3、TrkA、TrkB和TrkC中的一个或多个活性相关的疾病和症状，包括类风湿性关节炎、骨关节炎、骨质疏松症、周围假体周围骨溶解、系统性硬化、脱髓鞘疾病、多发性硬化症、沙科特-玛丽-屈氏综合征、肌萎缩性侧索硬化、阿尔茨海默病、帕金森病、全球性缺血、溃疡性结肠炎、克罗恩病、免疫性血小板减少性紫癜、动脉粥样硬化、系统性红斑狼疮、自体移植的骨髓准备、移植排斥、肾小球肾炎、间质性肾炎、狼疮性肾炎、肾小管坏死、糖尿病性肾病、肾肥大、I型糖尿病、急性疼痛、炎症性疼痛、神经病性疼痛、急性髓样白血病、黑色素瘤、多发性骨髓瘤、乳腺癌、前列腺癌、胰腺癌、肺癌、卵巢癌、胶质瘤、胶质母细胞瘤、神经纤维瘤病、骨转移性溶骨病、脑转移瘤、胃肠道间质瘤和巨细胞瘤。
• [EN] PRODUCTION METHOD OF IMIDAZOLE DERIVATIVES<br/>[FR] PROCÉDÉ DE PRODUCTION DE DÉRIVÉS D'IMIDAZOLE
  申请人：TAKEDA PHARMACEUTICAL

  公开号：WO2012173280A1

  公开（公告）日：2012-12-20

  The present invention provides an advantageous production method of an imidazole derivative, which is suitable for industrial production. Compound (VI) is produced by reacting compound (I) with a Grignard reagent or a magnesium reagent, and a lithium reagent, and then reacting the resulting compound with compound (V).

  本发明提供了一种有利于工业生产的咪唑衍生物的生产方法。化合物（VI）通过将化合物（I）与格氏试剂或镁试剂以及锂试剂反应，然后将所得化合物与化合物（V）反应而产生。